Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases

Agata Mostkowska, Guy Rousseau, Noël J-M Raynal
doi: https://doi.org/10.1101/2023.09.22.23295633

Article Information

doi 
https://doi.org/10.1101/2023.09.22.23295633
History 
  • September 25, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Agata Mostkowska1,
  2. Guy Rousseau1 and
  3. Noël J-M Raynal1,*
  1. 1Department of Pharmacology and Physiology, Faculty of Medicine, University of Montreal, Quebec, H3T 1C5, Canada
  1. ↵*Corresponding author:
    noel.raynal{at}umontreal.ca
Back to top
Posted September 25, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases
Agata Mostkowska, Guy Rousseau, Noël J-M Raynal
medRxiv 2023.09.22.23295633; doi: https://doi.org/10.1101/2023.09.22.23295633
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area